WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade Gliomas

BACKGROUND: While molecular insights to diffuse lower-grade glioma (dLGG) have improved the basis for prognostication, most established clinical prognostic factors come from the pre-molecular era. For instance, WHO grade as a predictor for survival in dLGG with isocitrate dehydrogenase (IDH) mutatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Carstam, Louise, Corell, Alba, Smits, Anja, Dénes, Anna, Barchéus, Hanna, Modin, Klara, Sjögren, Helene, Ferreyra Vega, Sandra, Bontell, Thomas Olsson, Carén, Helena, Jakola, Asgeir Store
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785215/
https://www.ncbi.nlm.nih.gov/pubmed/35083156
http://dx.doi.org/10.3389/fonc.2021.803975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785215/
https://www.ncbi.nlm.nih.gov/pubmed/35083156
http://dx.doi.org/10.3389/fonc.2021.803975

Ejemplares similares